No Data
Global Newborn Screening Market Report to 2031 - Players Include Agilent Technologies, Bio-Rad Laboratories, Covidien and GE Healthcare - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Newborn Screening Market By Product Type, By Test Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to
Head-To-Head Analysis: Bio-Rad Laboratories (NYSE:BIO.B) Versus Cue Health (NASDAQ:HLTH)
Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on
FDA Updates COVID-19 Test Policy to Cut Emergency Use Requests
Revising its COVID-19 test policy, the U.S. Food and Drug Administration (FDA) said Tuesday that the agency would review only a small number of new emergency use authorization (EUA) requests for diagn
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd
Sumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 10.6% in the second quarter, according to its most recent fil
Rosenberg Matthew Hamilton Buys 39 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Rosenberg Matthew Hamilton lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 65.0% in the second quarter, according to its most recent Form 13F filing with the Secu
Parkside Financial Bank & Trust Has $26,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Parkside Financial Bank & Trust raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 80.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned
Gateway Investment Advisers LLC Raises Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Gateway Investment Advisers LLC raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 50.7% in the 2nd quarter, according to its most recent 13F filing with the Securities &am
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Amalgamated Bank
Amalgamated Bank lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 6.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Co
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Today we will run through one way of estimating the intrinsic value of Bio-Rad Laboratories, Inc. (NYSE:BIO) by projecting its future cash flows and then discounting them to today's value. Our analys
Zacks Research Brokers Increase Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) – Stock analysts at Zacks Research lifted their Q2 2023 EPS estimates for Bio-Rad Laboratories in a note issued to investors on Tuesday, Septembe
Loading...
